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We have investigated the effect of tumor necrosis factor on the release of 
interleukin-1 and PGE from murine resident peritoneal macrophages. Tumor 
necrosis factor causes'an increase in the production of interleukin-1 and PGE 
with a maximum induction for both noted at 5.9 x 10m8M. While indomethaci i !  
decreased tumor necrosis factor induced PGE2 production, this cyclooxygenase 
inhibitor augmented tumor necrosis factor induced interleukin-1 production. 
Our data suggests that tumor necrosis factor may be an important immuno- 
potentiating agent in addition to its previously described cytolytic and 
metabolic activities. D 1986 Academic Press, Inc. 
A number of common biochemical and physiological alterations can be 
observed in animals responding to an in vivo challenge of bacteria or bacterial -- 
products. These derangements include an elevated body temperature (l), muscle 
catabolism (2), increase in acute phase proteins (3), immune effector cell 
activation (4,5), and hyperlipidemia (6). Current evidence has demonstrated 
that the above responses are attributable to monocyte/macrophage-derived 
peptides that are produced and released upon appropriate stimulation. One such 
peptide, tumor necrosis factor (TNF) , was originally described by Carswell as 
an oncolytic agent found in the serum of BCG immunized mice challenged with 
endotoxin (7). Although the initial interest focused on the cytotoxic effect 
of TNF, recent evidence has demonstrated that TNF and structurally homologous 
peptides, such as cachectin, must be considered as compounds that can stimulate 
Abbreviations used in this paper:TNF, tumor necrosis factor; IL-l, 
interleukin-1; PGE2, prostaglandin E2; LPS, lipopolysaccharide. 
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a variety of cellular responses associated with an immune event. These 
activities range from augmenting inflammatory cell activity by increasing 
neutrophil phagocytic and cytotoxic activity to suppressing the production of 
lipoprotein lipase resulting in the mobilization of energy reserves (8,9). 
In the present paper we demonstrate the ability of TNF to stimulate the 
production of interleukin-1 (IL-l) and prostaglandin E2 (PGE2) from resident 
peritoneal macrophages. This additional, novel activity of TNF may contribute 
to macrophage-mediated immune reactions by serving as a signal responsible for 
the continued maintenance of the inflammatory reaction. These signals may 
provide a unique means for cells participating in local inflammatory lesions to 
communicate with other immune cells, resulting in amplified and/or modulated 
immune response. 
MATERIALS AND METHODS 
Animals - Female, specific pathogen-free C3H/HeJ, endotoxin resistant, and 
CBA/J endotoxin sensitive mice (Jackson Laboratories, Bar Harbor, ME) were used 
throughout the experiments. Mice were maintained under pathogen-free condi- 
tions and given food and water ad libitum. 
Macrophage cultures - Mouse blood monocytes and resident peritoneal 
macrophages were obtained as prgviously described (10). Cells were washed, 
counted, and suspended to 1 x 10 /ml RPM1 with 5% fetal bovine serum (FBS) and 
100 U penicillin/100 pg streptomycin/ml. One ml of the cell suspension was 
dispensed onto 35 mm sterile plastic culture dishes (Corning Glass Works, 
Corning, NY). After 2h incubation, (37O, 5% COP, 100% humidity) nonadherent 
cells were removed by two vigorous rinses. 
The monolayers were overlaid with 1 ml of serum-free media (RPM1 with 
anfibiotics) plus various concentrations of recombinant TNF (specific activity 
10 units/mg, Mw 17,000). Purified rTNF (lot #LYMlZ-072685C) and rabbit o 
human TNF neutralizing antibody (lot 57-030685) were provided as gifts by Dr. 
Leo S. Lin; Cetus Corp., Emeryville, CA. Endotoxin contamination of 1 ug/ml 
TNF was less than 150 pg/ml. Iqqomethacin (Sigma Chemical Co., St. Louis, MO) 
at a final concentration of 10 M and/or Salmonella lipopolysaccharide (LPS) 
(Sigma Chem. Co., St. Louis, MO) at 10 pg/ml were used in specified plates. 
Supernatants were collected after 16h incubation. The total number of adherent 
macrophages was quantitated by scraping the cells and counting in a hemocytome- 
ter. The adherent cells were >95% macrophages by morphology and phagocytic 
index. 
Radioimminoassay for Prostaglandins E - The macrophage culture medium was 
collected, centrifuged at 500 xg for 10 m n and then subjected to radioimmuno- 
assay for. PGE 
f 
as described by Fitzpatrick et al. (11). Briefly, samples were 
extracted to emove protein and free fatty acids before addition of antibodies. 
Bound and free ligand were separated using dextran-coated charcoal. Sensitiv- 
ity for PGE was 8 picograms. 
Inter1 E ukin-1 assay 
proliferation assay (12). 
- Interleukin-1 wgs measured by the standard thymocyte 
Briefly, 5 x 10 mouse thymocytes in 0.1 ml RPMI-10% 
FBS containing 2.5 pg/ml PHA (Burroughs Welcome, Research Triangle, NC) were 
distributed into each well of a 96-well sterile culture dish (Costar, 
Cambridge, Mass.). Equal volumes of serially diluted test supernate were then 
added to triplicate wells. Control wells contained no PHA. At 64h of incuba- 
tion, the cells were pulsed with 0.5 uCi of tritiated thymidine then harvested 
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at 72h. Total thymidine incorporation was determined by liquid scintillation 
spectrophotometry. Augmentation of PHA-induced thymocyte proliferation indi- 
cated IL-1 activity. Data represents quantitation of PHA responses using 1:8 
dilutions of macrophage culture supernatants. 
Statistical analysis - The Student's t-test was used to compare control 
and experimental groups. Values of p > .05 were considered not significant. 
RESULTS 
Effect of TNF on IL-1 Production - Initially, we examined the effects of 
varying amounts of TNF to induce the release of IL-1 from resident peritoneal 
macrophage. Control culture supernatants revealed no IL-1 activity beyond 
media alone, while TNF caused statistically significant increase in IL-1 
production (Fig. 1). A greater than 8-fold increase in the production of IL-1 
by resident macrophages was observed when stimulated with 5.9 x 10q8M TNF. 
Augmented IL-1 production by blood monocytes treated with the same doses of TNF 
was also observed, but the percent increase above control levels were signifi- 
cantly lower (data not shown). An augmentation of the TNF effect on resident 
peritoneal macrophages was observed with the cyclooxygenase inhibitor indometh- 
acin. Treatment with 10e7M indomethacin resulted in nearly a P-fold increase 
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Figure 1. Effect of TNF on the production of IL-l from resident peritoneal 
macrophages. Macrophage cultures (2.5 x 105/dish) were incubated for 
16h with the TNF and supernatants were then tested for IL-l activity. 
TNF alone had no effect on the proliferation assay. 
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Table 1. Effect of TNF in the presence of either LPS or 10W7M indomethacin 
Culture condition 
Control 
3HTdR incorporation (CPM) 
921 2 101 
LPS (10 pg/ml) 12,069 f 1,050 
TNF (5.9 x lO-8M) 
TNF (5.9 x 10-8M) 
+ Indomethacin (10e7M> 
9,540 * 1,125 
18,390 f  2,350 
TNF (5.9 x 10-8M) 
+ LPS (10 pg/ml) 
23,510 * 4,900 
Theabove data is representativeof quadruplicateexperiments. SimilarTNF-induced IL-l production 
was observed with both CBA/J and C3H/HeJ macrophages. In the absence of macrophage super- 
natant, PHA alone gave 523 + 250 cpm. In addition, 0.25 units of commercially available 
IL-l (Cistron Technology, Pinebrook, N.J.) gave 9763 ? 1,610 cpm. To quantitate TNF 
activity, 5.9 x 10e8M = 1.0 ug/ml = lo4 units/ml. 
in TNF-induced IL-l production (Table 1). The magnitude of the increase in 
TNF-induced IL-1 production was significant, as 5.9 x 10e8M (lpg/ml) TNF 
induced similar levels of IL-1 production as 10 pg/ml of LPS. The addition 
of both LPS and TNF to the resident peritoneal macrophage cultures resulted 
in an additive effect on the production of IL-1 (Table 1); suggesting that 
resident peritoneal macrophages are susceptible to simultaneous stimuli that 
may enhance IL-1 production. Of particular interest was the additive effect Of 
LPS and TNF on IL-l production by C3H/HeJ, LPS resident mice. Although these 
mice showed a decrease in the release of IL-l in response to LPS (10 pg/ml), 
the concomitant addition of LPS (10 yg/ml) plus TNF (1 pg/ml) resulted in an 
approximate Z-fold increase above TNF alone. In addition, TNF may serve as a 
potent stimulus for non-elicited resident macrophages and blood monocytes, 
since elicited macrophages are not nearly as receptive to TNF challenge. TNF 
alone had no effect on the thymocyte proliferation assay. 
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Figure 2. Levels of PGE2 generated by resident peritoneal macrophages in 
response to graded doses of TNF. The concentration of PGE2 repre- 
sents the mean of 4 individual experiments. 
Effect of TNF on PGE, Production. We next determined the effect of TNF on 
the production of PGE2 by the cultured macrophages. As shown in Figure 2, TNF 
demonstrated a statistically significant increase in the production of PGE2. 
The amount of TNF needed to induce PGE2 production was nearly identical to that 
for TNF-induced IL-l production, as PGE2 production plateaued at a TNF concon- 
centration of 5.9 x 10w8M. Indomethacin (10e7M) treatment reduced the levels 
of TNF-induced PGE2 production by 80-85%. (5.9 x 10m8M TNF = 33 ng PGE2/106 
cells and 5.9 x 10v8M TNF + 10w7M indomethacin = 5 ng PGE2/ lo6 cells.) These 
data suggest that TNF-induced IL-l production may be under the regulatory 
influence of specific cyclooxygenase derived metabolites. 
Specificity of TNF Induced IL-l Release. We next examined the specificity 
of the TNF response to document that the IL-l release induced by TNF was 
specific and not solely related to endotoxin contamination (Table 2). Heating 
TNF at 56OC for 30 minutes destroyed the majority of TNF induced IL-l activity, 
while endotoxin activity was unaffected. Heated TNF resulted in a greater than 
80% reduction in TNF induced IL-l release compared to unheated TNF, while 
heated and unheated LPS induced similar amounts of IL-l. Furthermore, addition 
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Table 2. TNF induced release of IL-l is specific and not totally endotoxin dependent 
3 
H TdR incorporation 
Experiment 
1 
Culture condition (cpm/106 cells) 
TNF (1 ug/ml) 11,708 f  1018 
LPS (10 ug/ml) 14,187 2 938 
* 10m8M) heated TNF (5.9 x (1 ug/ml) 2096 2 344 
* 
heated LPS (10 ug/ml) 17,261 f 10,597 
2 TNF (2.9 x 10m7M) (5 ug/ml) 
TNF (2.9 x 10T7M) (5 yg/ml) 
+ CYTNF antibody+ 
13,181 f 2201 
1219 + 284 
3 TNF (5.9 x 10m8M) (1 ug/ml) 11,826 f 1072 
(C3H/HeJ mice) LPS (1 ug/ml) 2742 + 825 
Theabove data is representativeoftriplicateexperiments. Commercially available IL-1 (0.25 
units; Cistron Technology, Pinebrook, N.J.) gave 6744 f 1446. Control macrophage superna- 
tants without an added stimulus gave 5-10% of the TNF stimulated supernatants. Neutraliza- 
tion of TNF activity by either heating at 56°C for 30 min* or adding neutralizing oTNF 
antibody? was verified by showing protection of L-929 cells from TNF induced cytolysis. 
of specific crTNF neutralizing antibodies reduced TNF induced IL-1 production by 
90% (Table 2). Lastly, peritoneal macrophages from LPS resistant mice 
(C3H/HeJ) responded to TNF stimulation with IL-1 release, while LPS was not as 
effective in inducing IL-1 from this strain of mouse. 
DISCUSSION 
It is well known that macrophages are capable of producing several impor- 
tant molecular signals during the initiation and maintenance of inflammatory 
reactions. Interleukins, prostaglandins, and tumor necrosis factor are all 
important members of a spectrum of highly refined mediators that may dictate 
the course of immune responses. Despite their potential importance in immune 
reactions, the bidirectional communication between these mediators has not been 
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described. In this paper, we present direct evidence that TNF can stimulate 
macrophages to produce IL-l, and that cyclooxygenase pathway inhibition can 
augment this effect. The latter observation is supported by the fact that TNF 
can stimulate PGE2 production by cultured macrophages. 
The mechanism by which TNF stimulates IL-1 production remains unclear. 
The effect is not simply due to the presence of LPS in the TNF preparations 
because: a) the magnitude of the IL-1 release induced by TNF is far greater 
than can be explained by low concentrations of LPS; b), the induction of IL-l 
release by TNF was markedly decreased by heating or by the addition of CYTNF 
neutralizing antibody; c), macrophages from endotoxin resistant mice released 
IL-1 in response to TNF; and d) TNF and LPS act in an additive manner to 
stimulate macrophages to produce more IL-l than either substance alone. This 
synergistic activity may have important consequences in clinical states, such 
as sepsis, where both endotoxin and TNF may be present (13). Under such 
conditions these signals could act to accelerate the numerous metabolic and 
immunologic derangements that are associated with this malady. The augmented 
production of IL-1 by TNF and LPS could contribute to cachexia, by accelerating 
skeletal-muscle proteolysis (2); could contribute to physiologic changes, by 
inducing fever (1); and could contribute to immune alterations, by activating 
various inflammatory cells (4,5). 
Our data may also serve as a model for the regulation of an additional 
macrophage-derived mediator by PGE2. Recently, we have demonstrated that PGE2 
is an endogenous modulator of LPS-i nduced macrophage IL-1 production (10,14). 
Moreover, IL-l possesses the characteristics of a hormone by inducing its own 
suppressing mechanism. The ability of TNF to induce PGE2 production and 
augment IL-1 production in the presence of indomethacin suggests that this 
cyclooxygenase metabolite plays an important regulatory role with regard to an 
additional macrophage secretory product. 
In conclusion, we provide evidence that TNF can induce IL-l and PGE2 
production by resident peritoneal macrophages and the production of IL-1 is 
augmented by inhibition of the cyclooxygenase pathway of arachidonic acid 
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metabolism. These data support the notion that TNF is much more than an 
oncolytic agent and may play an important role in numerous macrophage-mediated 
events. 
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